Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Treatment of Relapsed Acute Myeloid Leukemia135
Targeted Therapies in Advanced Gastric Cancer129
Metabolic Aspects of Anthracycline Cardiotoxicity48
Tumor Treating Fields in the Management of Patients with Malignant Gliomas48
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma44
Models of Integration of Specialized Palliative Care with Oncology40
Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy36
Systemic Therapy for Metastatic Pancreatic Cancer35
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates33
The Importance of Prognostication: Impact of Prognostic Predictions, Disclosures, Awareness, and Acceptance on Patient Outcomes33
Optimal Strategies for Colorectal Cancer Screening28
Defining and Targeting BRAF Mutations in Solid Tumors27
New Treatment Options for Advanced Biliary Tract Cancer27
Understanding and Supporting Informal Cancer Caregivers26
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults26
Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations25
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms25
Immunotherapy in Hepatocellular Carcinoma25
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma25
BRAF Heterogeneity in Melanoma24
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer24
Optimal Management of Corticosteroids in Patients with Intracranial Malignancies22
Contemporary Management of Anaplastic Thyroid Cancer22
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past22
Cardiovascular Toxicities of Androgen Deprivation Therapy21
Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy21
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer21
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies21
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy20
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy20
Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer20
Janus Kinase Inhibitors and Non-Melanoma Skin Cancer19
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma19
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives19
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment19
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer19
Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?19
Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone18
Constipation in Cancer Patients — an Update of Clinical Evidence18
Systemic Options for Malignant Peripheral Nerve Sheath Tumors18
Appropriate Selection of PARP Inhibitors in Ovarian Cancer17
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches17
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients17
Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors16
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma16
Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation16
Progress on Management of Penile Cancer in 202016
Evaluation and Management of Sleep and Circadian Rhythm Disturbance in Cancer16
The Benefits of Olanzapine in Palliating Symptoms15
The Evolving Landscape of HER2-Directed Breast Cancer Therapy15
Role of TKI for Metastatic Osteogenic Sarcoma15
Current Status of CAR T Cell Therapy for Leukemias15
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?15
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms15
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?15
Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities14
The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature14
Family Meetings in Palliative Care: Benefits and Barriers14
Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?14
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects14
Immunotherapy and Biomarkers in Sarcoma14
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)14
Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma14
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy13
Leveraging Social Media for Cardio-Oncology13
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer13
Management of Laryngeal Dysplasia and Early Invasive Cancer13
Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy13
Systemic Therapy for Lung Cancer Brain Metastases13
Symptom Management in Pancreatic Cancer13
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients13
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations12
Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials12
Treatment Strategies for Oligometastatic Breast Cancer12
Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development12
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy12
Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma12
Exercise Training for Cancer Survivors12
Treating Chronic Pain with Buprenorphine—The Practical Guide12
Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments12
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis12
HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles12
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities12
New Approaches to Myelodysplastic Syndrome Treatment12
Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas11
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy11
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?11
Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time11
BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia11
HER2-Low Breast Cancer: a New Subtype?11
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?11
Treatment Approach to Adenocarcinoma of the Ampulla of Vater10
New Treatment Options for Older Patients with Acute Myeloid Leukemia10
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma10
Drug Repurposing in Medulloblastoma: Challenges and Recommendations10
The Role of Oncoplastic Surgery for Breast Cancer10
Nectin-4: a Novel Therapeutic Target for Skin Cancers10
Treatment personalization in gastrointestinal neuroendocrine tumors10
New Treatment Strategies for the Inflammatory Breast Cancer10
Anatomic and Functional Imaging of Neuroendocrine Tumors10
Surgical Management of Skull Base and Spine Chordomas10
Approach to Localized Squamous Cell Cancer of the Esophagus10
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives10
New Immuno-oncology Targets and Resistance Mechanisms10
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure10
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now10
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer10
Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions10
Cardiovascular Toxicities of Bruton’s Tyrosine Kinase Inhibitors9
Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors9
Defining and Treating Borderline Resectable Pancreatic Cancer9
A Review of Pharmacologic Management in the Treatment of Mesothelioma9
Management of Cutaneous Angiosarcoma: an Update Review9
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers9
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity9
Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma9
Advanced Acral Melanoma Therapies: Current Status and Future Directions9
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers9
Targeted Therapy for Melanomas Without BRAF V600 Mutations9
0.05038595199585